All Categories
Contact Us
Awaiting product image

CABOTIB 80MG TAB

Request a Quote
Share :

Related Products

Toritz 100mg

CABOTIB 80MG TAB is a prescription medication used to treat certain types of cancer, including:
  • Hepatocellular carcinoma (HCC) in patients with advanced disease who have not responded to previous therapy
  • Intrahepatic cholangiocarcinoma (iCC) in patients with advanced disease who have not responded to previous therapy
  • Non-small cell lung cancer (NSCLC) in patients with advanced disease who have not responded to previous therapy
It is a tyrosine kinase inhibitor that works by blocking the action of the c-MET protein, which is involved in the development and growth of cancer cells. Composition: Each tablet of CABOTIB 80MG TAB contains 80mg of cobozantinib. Mechanism of Action: Cobozantinib works by:
  • Blocking the action of the c-MET protein, which is involved in the development and growth of cancer cells
  • Inhibiting the formation of new blood vessels that feed the tumor
  • Reducing the growth and proliferation of cancer cells
Uses: CABOTIB 80MG TAB is used to treat certain types of cancer, including:
  • Hepatocellular carcinoma (HCC) in patients with advanced disease who have not responded to previous therapy
  • Intrahepatic cholangiocarcinoma (iCC) in patients with advanced disease who have not responded to previous therapy
  • Non-small cell lung cancer (NSCLC) in patients with advanced disease who have not responded to previous therapy
Dosage: The recommended dosage of CABOTIB 80MG TAB is:
  • 80mg taken orally once daily, with or without food
Side Effects: Common side effects of CABOTIB 80MG TAB include:
  • Diarrhea
  • Fatigue
  • Nausea and vomiting
  • Abdominal pain
  • Rash
  • Constipation
  • Decreased appetite
Recommendation: CABOTIB 80MG TAB is recommended for patients who have not responded to previous therapy for their specific type of cancer. Patients should also be advised to monitor their liver function and thyroid function regularly during treatment. Important Note: Patients should not take CABOTIB 80MG TAB if they have a history of severe allergic reactions, bleeding disorders, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as liver or kidney problems, before taking CABOTIB 80MG TAB. Some common brands of cobozantinib include:
  • Cabometyx (Exelixis)
  • Cabozantinib (Exelixis)
Please note that CABOTIB 80MG TAB is not available in all markets and may be approved for different indications and dosages in different regions.

CABOTIB 80MG TAB is a prescription medication used to treat certain types of cancer, including:

  • Hepatocellular carcinoma (HCC) in patients with advanced disease who have not responded to previous therapy
  • Intrahepatic cholangiocarcinoma (iCC) in patients with advanced disease who have not responded to previous therapy
  • Non-small cell lung cancer (NSCLC) in patients with advanced disease who have not responded to previous therapy

It is a tyrosine kinase inhibitor that works by blocking the action of the c-MET protein, which is involved in the development and growth of cancer cells.

Composition:

Each tablet of CABOTIB 80MG TAB contains 80mg of cobozantinib.

Mechanism of Action:

Cobozantinib works by:

  • Blocking the action of the c-MET protein, which is involved in the development and growth of cancer cells
  • Inhibiting the formation of new blood vessels that feed the tumor
  • Reducing the growth and proliferation of cancer cells

Uses:

CABOTIB 80MG TAB is used to treat certain types of cancer, including:

  • Hepatocellular carcinoma (HCC) in patients with advanced disease who have not responded to previous therapy
  • Intrahepatic cholangiocarcinoma (iCC) in patients with advanced disease who have not responded to previous therapy
  • Non-small cell lung cancer (NSCLC) in patients with advanced disease who have not responded to previous therapy

Dosage:

The recommended dosage of CABOTIB 80MG TAB is:

  • 80mg taken orally once daily, with or without food

Side Effects:

Common side effects of CABOTIB 80MG TAB include:

  • Diarrhea
  • Fatigue
  • Nausea and vomiting
  • Abdominal pain
  • Rash
  • Constipation
  • Decreased appetite

Recommendation:

CABOTIB 80MG TAB is recommended for patients who have not responded to previous therapy for their specific type of cancer. Patients should also be advised to monitor their liver function and thyroid function regularly during treatment.

Important Note:

Patients should not take CABOTIB 80MG TAB if they have a history of severe allergic reactions, bleeding disorders, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as liver or kidney problems, before taking CABOTIB 80MG TAB.

Some common brands of cobozantinib include:

  • Cabometyx (Exelixis)
  • Cabozantinib (Exelixis)

Please note that CABOTIB 80MG TAB is not available in all markets and may be approved for different indications and dosages in different regions.

Shipping Options – 

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions – 

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

CABOTIB 80MG TAB is a prescription medication used to treat certain types of cancer, including:

  • Hepatocellular carcinoma (HCC) in patients with advanced disease who have not responded to previous therapy
  • Intrahepatic cholangiocarcinoma (iCC) in patients with advanced disease who have not responded to previous therapy
  • Non-small cell lung cancer (NSCLC) in patients with advanced disease who have not responded to previous therapy

It is a tyrosine kinase inhibitor that works by blocking the action of the c-MET protein, which is involved in the development and growth of cancer cells.

Composition:

Each tablet of CABOTIB 80MG TAB contains 80mg of cobozantinib.

Mechanism of Action:

Cobozantinib works by:

  • Blocking the action of the c-MET protein, which is involved in the development and growth of cancer cells
  • Inhibiting the formation of new blood vessels that feed the tumor
  • Reducing the growth and proliferation of cancer cells

Uses:

CABOTIB 80MG TAB is used to treat certain types of cancer, including:

  • Hepatocellular carcinoma (HCC) in patients with advanced disease who have not responded to previous therapy
  • Intrahepatic cholangiocarcinoma (iCC) in patients with advanced disease who have not responded to previous therapy
  • Non-small cell lung cancer (NSCLC) in patients with advanced disease who have not responded to previous therapy

Dosage:

The recommended dosage of CABOTIB 80MG TAB is:

  • 80mg taken orally once daily, with or without food

Side Effects:

Common side effects of CABOTIB 80MG TAB include:

  • Diarrhea
  • Fatigue
  • Nausea and vomiting
  • Abdominal pain
  • Rash
  • Constipation
  • Decreased appetite

Recommendation:

CABOTIB 80MG TAB is recommended for patients who have not responded to previous therapy for their specific type of cancer. Patients should also be advised to monitor their liver function and thyroid function regularly during treatment.

Important Note:

Patients should not take CABOTIB 80MG TAB if they have a history of severe allergic reactions, bleeding disorders, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as liver or kidney problems, before taking CABOTIB 80MG TAB.

Some common brands of cobozantinib include:

  • Cabometyx (Exelixis)
  • Cabozantinib (Exelixis)

Please note that CABOTIB 80MG TAB is not available in all markets and may be approved for different indications and dosages in different regions.

Reviews

There are no reviews yet.

Be the first to review “CABOTIB 80MG TAB”

Your email address will not be published. Required fields are marked *

CABOTIB 80MG TAB is a prescription medication used to treat certain types of cancer, including:

  • Hepatocellular carcinoma (HCC) in patients with advanced disease who have not responded to previous therapy
  • Intrahepatic cholangiocarcinoma (iCC) in patients with advanced disease who have not responded to previous therapy
  • Non-small cell lung cancer (NSCLC) in patients with advanced disease who have not responded to previous therapy

It is a tyrosine kinase inhibitor that works by blocking the action of the c-MET protein, which is involved in the development and growth of cancer cells.

Composition:

Each tablet of CABOTIB 80MG TAB contains 80mg of cobozantinib.

Mechanism of Action:

Cobozantinib works by:

  • Blocking the action of the c-MET protein, which is involved in the development and growth of cancer cells
  • Inhibiting the formation of new blood vessels that feed the tumor
  • Reducing the growth and proliferation of cancer cells

Uses:

CABOTIB 80MG TAB is used to treat certain types of cancer, including:

  • Hepatocellular carcinoma (HCC) in patients with advanced disease who have not responded to previous therapy
  • Intrahepatic cholangiocarcinoma (iCC) in patients with advanced disease who have not responded to previous therapy
  • Non-small cell lung cancer (NSCLC) in patients with advanced disease who have not responded to previous therapy

Dosage:

The recommended dosage of CABOTIB 80MG TAB is:

  • 80mg taken orally once daily, with or without food

Side Effects:

Common side effects of CABOTIB 80MG TAB include:

  • Diarrhea
  • Fatigue
  • Nausea and vomiting
  • Abdominal pain
  • Rash
  • Constipation
  • Decreased appetite

Recommendation:

CABOTIB 80MG TAB is recommended for patients who have not responded to previous therapy for their specific type of cancer. Patients should also be advised to monitor their liver function and thyroid function regularly during treatment.

Important Note:

Patients should not take CABOTIB 80MG TAB if they have a history of severe allergic reactions, bleeding disorders, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as liver or kidney problems, before taking CABOTIB 80MG TAB.

Some common brands of cobozantinib include:

  • Cabometyx (Exelixis)
  • Cabozantinib (Exelixis)

Please note that CABOTIB 80MG TAB is not available in all markets and may be approved for different indications and dosages in different regions.

Reviews

There are no reviews yet.

Be the first to review “CABOTIB 80MG TAB”

Your email address will not be published. Required fields are marked *

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.
abbott
Ferring Pharmaceuticals 1
bdr
celon pharma
alkem
AstraZeneca
Aurobindo
biocon
bsv pharma
cipla
esisi
dr reddy
emsure
lilly
Glenmark Pharmaceuticals
gsk
Fresenius Kabi
gls
hetero
intas pharma
Jenome Biophar
Laurus Labs Limited
Miracalus Pharma
msd
mylan
neaon
Natco Pharma Limited
novartis
Panacea Biotec
Pfizer Inc
Ranbaxy Pharmaceuticals Inc
roche
rgp
Samarth Life
sandoz
sarabhai
sun pharma
torrent pharma
3e963ab60b4cd83959187883e457451f_200x200
zydus
Scroll to Top

Log in

Create an Account

Send Enquiry For CABOTIB 80MG TAB